JP2023515539A5 - - Google Patents
Info
- Publication number
- JP2023515539A5 JP2023515539A5 JP2022550963A JP2022550963A JP2023515539A5 JP 2023515539 A5 JP2023515539 A5 JP 2023515539A5 JP 2022550963 A JP2022550963 A JP 2022550963A JP 2022550963 A JP2022550963 A JP 2022550963A JP 2023515539 A5 JP2023515539 A5 JP 2023515539A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- amount
- diclofenac
- use according
- daily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026038922A JP2026116929A (ja) | 2020-02-27 | 2026-03-11 | 外用ジクロフェナク組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062982589P | 2020-02-27 | 2020-02-27 | |
| US62/982,589 | 2020-02-27 | ||
| PCT/NL2021/050125 WO2021172987A1 (en) | 2020-02-27 | 2021-02-25 | Topical diclofenac compositions and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026038922A Division JP2026116929A (ja) | 2020-02-27 | 2026-03-11 | 外用ジクロフェナク組成物及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515539A JP2023515539A (ja) | 2023-04-13 |
| JP2023515539A5 true JP2023515539A5 (cg-RX-API-DMAC7.html) | 2024-03-01 |
Family
ID=74858737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550963A Pending JP2023515539A (ja) | 2020-02-27 | 2021-02-25 | 外用ジクロフェナク組成物及び方法 |
| JP2026038922A Pending JP2026116929A (ja) | 2020-02-27 | 2026-03-11 | 外用ジクロフェナク組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026038922A Pending JP2026116929A (ja) | 2020-02-27 | 2026-03-11 | 外用ジクロフェナク組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230157979A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4110320A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023515539A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115279360A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021228521B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022016887A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3169241A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022010593A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021172987A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2538856C (en) | 2003-10-10 | 2010-06-29 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
| EP2055298A1 (en) * | 2007-10-30 | 2009-05-06 | Novartis AG | Topical composition |
| US20120157536A1 (en) * | 2010-12-20 | 2012-06-21 | Polytherapeutics, Inc. | Composition for transdermal administration of non-steroidal anti-flammatory drug |
| US9713590B2 (en) * | 2011-07-28 | 2017-07-25 | Cadila Healthcare Limited | Method for treatment of pain and inflammation |
| BR112015000329A2 (pt) | 2012-07-12 | 2017-06-27 | Ferring Bv | formulações de diclofenac |
| US20140113970A1 (en) * | 2012-10-22 | 2014-04-24 | Mallinckrodt LLC Covidien | Dispensing system |
| US9468618B2 (en) * | 2014-12-12 | 2016-10-18 | Lupin Atlantis Holdings Sa | Topical pharmaceutical gel composition of diclofenac sodium |
-
2021
- 2021-02-25 MX MX2022010593A patent/MX2022010593A/es unknown
- 2021-02-25 CA CA3169241A patent/CA3169241A1/en active Pending
- 2021-02-25 AU AU2021228521A patent/AU2021228521B2/en active Active
- 2021-02-25 BR BR112022016887A patent/BR112022016887A2/pt unknown
- 2021-02-25 EP EP21710069.2A patent/EP4110320A1/en active Pending
- 2021-02-25 CN CN202180019349.8A patent/CN115279360A/zh active Pending
- 2021-02-25 US US17/801,703 patent/US20230157979A1/en active Pending
- 2021-02-25 WO PCT/NL2021/050125 patent/WO2021172987A1/en not_active Ceased
- 2021-02-25 JP JP2022550963A patent/JP2023515539A/ja active Pending
-
2026
- 2026-03-11 JP JP2026038922A patent/JP2026116929A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4009944B1 (en) | Topical formulations comprising cannabidiol, method of preparing the composition and use thereof | |
| JP6434104B2 (ja) | ジクロフェナク製剤 | |
| JP2015522049A5 (cg-RX-API-DMAC7.html) | ||
| EP3689328A1 (en) | Compositions for relieving pain comprising malkangni oil and cypriol oil as active ingredients | |
| CN101641103B (zh) | 脱乙酰壳多糖在制备用于治疗指/趾甲炎症性疾病的药物中的用途 | |
| CN101972225A (zh) | 一种含吡非尼酮的凝胶组合物 | |
| JP4359140B2 (ja) | 異常な角質性物質を除去するための製剤 | |
| JP2024538277A (ja) | スキンケアにおける使用に好適な組成物 | |
| WO2016181355A1 (en) | Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity | |
| RU2496476C1 (ru) | Средство наружной терапии для больных атопическим дерматитом | |
| CN112135621A (zh) | 用于治疗阴道萎缩的组合物和方法 | |
| CN107441071B (zh) | 一种芳姜黄酮在制备治疗和/或预防银屑病药物中的应用 | |
| US20050152993A1 (en) | Composition for and method of treatment for skin ailments | |
| JPH03291222A (ja) | ジクロフェナック・ナトリウムを含有する局所用医薬組成物 | |
| AU2007200216A1 (en) | Skin formulation usable as a therapeutic application for the treatment of general skin disorders and a method of preparation thereof | |
| MX2023009424A (es) | Composicion antitranspirante. | |
| TWI911334B (zh) | 外用組成物 | |
| US11672769B2 (en) | Paraffin wax with CBD isolate | |
| CN108969531A (zh) | 聚乙二醇作为活性成分在制备银屑病治疗药物中的应用及其药物 | |
| WO2024042452A1 (en) | Topical composition for pain relief | |
| CN106943415B (zh) | 一种预防和治疗皮肤瘙痒的外用药物组合物及其制备方法和用途 | |
| JP2023515539A (ja) | 外用ジクロフェナク組成物及び方法 | |
| RU2706234C2 (ru) | Применение гидроксида калия при лечении актинического кератоза | |
| CN105434791A (zh) | 一种治疗腋臭的凝胶剂的配方组成及制备方法 | |
| CN115887421A (zh) | 一种复方糖皮质激素喷膜剂及其制备和应用 |